F9 and inflammatory bowel disease: As the prevalence of IBD was found to be reduced in hemophilic patients (Thompson et al., 1995), we were curious to explore whether coagulation factor IX-deficient (F9−/−) C57BL/6 mice (Lin et al., 1997) are protected against 3.5% DSS-induced acute intestinal inflammation.